Strategic investors have taken a closer look of late at shares of Bio-Rad Laboratories, Inc. (NYSE:BIO). Given the cheap price, many are wondering if there is now value and potential upside to the name. During the most recent session, shares touched $239.69 after moving 0.68%.
Here we’ll take a quick glance at how the stock price is currently trading in relation to some of its simple moving averages. At current levels, Bio-Rad Laboratories, Inc. (NYSE:BIO) shares have been seen trading -4.97% away from the 20-day moving average. The stock has been recently separated from the 50-day moving average by -4.72%. Using a broader approach, shares have been trading 2.62% off of the 200-day moving average. After the latest check-in, company stock is -12.48% off of the 50 day high and 3.76% away from the 50 day low price.
Analysts are predicting earnings per share growth of -75.30% for the current year. The earnings per share growth over the next five years are expected to be 24.16%. Bio-Rad Laboratories, Inc. has had earnings per share growth of -31.50% over the past five years.
Earnings per share (EPS) the amount of income that “belongs” to each share of common stock. This is a valuable tool that investors use to determine the value and projected value of a stock. Earnings per share is generally reported in annualized form from the most recent fiscal year. To determine the value, the average number of shares outstanding is usually calculated by averaging the number of shares at the beginning of the fiscal period and the number of shares at the end of the period.
Currently the return on equity is 0.90% and its debt to equity is 0.15. Bio-Rad Laboratories, Inc. has a total market cap of $8326.83, a gross margin of 55.50% while the profit margin is 1.10% and the ROI is 1.30%.
In terms of performance, we can pore into the stats for Bio-Rad Laboratories, Inc. (NYSE:BIO). The stock is 0.43% since the start of 2017. Over the past week, shares are -3.05%. Moving out to look at the previous month performance, the stock is at -4.59%. For the quarter, performance is at -10.32%. During the past six months, Bio-Rad Laboratories, Inc. (NYSE:BIO)’s stock has been 11.02% and 25.95% for the last 12 months.